EORTC-62092-22092-STBSG-ROG

Back to Clinical Trials Database

A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcomas (RPS) - STRASS

Study documentation

Trial Status	LT-FU ongoing
Dates	Date of activation: 16-Jan-2012 Date Step1 close: 11-Apr-2017
Data management at EORTC	Yes
Design	Phase 3 Randomized open label
Targeted Sample size	EORTC Groups: 256 - All Groups: 256
Treatment	Radiotherapy, Surgery
Study Staff	Sylvie Bonvalot (Study Coordinator) , Institut Curie- Hopital de Paris, PARIS CEDEX 05 Rick Haas (Study Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam Stephanie Kromar (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Saskia Litiere (Statistician) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Axelle Nzokirantevye (Data Manager) , EORTC Headquarters, Brussels Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Ionela Stanciu (Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer	Soft Tissue and Bone Sarcoma
Participating groups	EORTC Radiation Oncology Group EORTC Soft Tissue and Bone Sarcoma Group
Recruiting centers	CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole (TOULOUSE CEDEX 9, France) Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame (Montreal, Canada) Centre Leon Berard (Lyon, France) Centro Di Riferimento Oncologico (Aviano, Italy) Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America) Gustave Roussy (VILLEJUIF CEDEX, France) Herlev Hospital - University Copenhagen (Herlev, Denmark) Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain) Hospital Universitario San Carlos (Madrid, Spain) IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy) IRCCS - Istituto Oncologico Veneto (Padova, Italy) Institut Bergonie (Bordeaux, France) Institut Curie- Hopital de Paris (PARIS CEDEX 05, France) Institut Jules Bordet (Brussels, Belgium) Istituto Clinico Humanitas (Rozzano, Milano, Italy) Karolinska University Hospital, location Solna (Stockholm, Sweden) Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom) Leiden University Medical Centre (Leiden, Netherlands) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Mount Sinai Hospital (Toronto, Ontario, Canada) NHS Lothian - Western General Hospital (Edinburgh, United Kingdom) Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Oslo University Hospital - Radiumhospitalet (Oslo, Norway) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom) Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany) The Christie NHS Foundation Trust (Manchester, United Kingdom) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) UHB-Queen Elisabeth Medical Centre (Birmingham, United Kingdom) UniversitaetsMedizin Mannheim (Mannheim, Germany) Universitaetsklinikum Koeln (Koeln, Germany) University College Hospital (London, United Kingdom) University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom) University Medical Center Groningen (Groningen, Netherlands)
Centers to be activated	CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole (TOULOUSE CEDEX 9, France)
Protocol summary	http://clinicaltrials.gov/ct/show/NCT01344018
NCT number	NCT01344018
Financial Support	Academic Fund EORTC Group External Grant